Short-term Outcomes of Corticosteroid Monotherapy in Multisystem Inflammatory Syndrome in Children.
Sign Up to like & getrecommendations! Published in 2022 at "JAMA pediatrics"
DOI: 10.1001/jamapediatrics.2022.0292
Abstract: Importance Optimal agents and duration of primary treatment for multisystem inflammatory syndrome in children (MIS-C) remain unclear. Objective To compare short-term patient outcomes based on initial treatment with corticosteroids, intravenous immunoglobulin (IVIG), or both. Design,… read more here.
Keywords: group; plus corticosteroids; ivig plus; corticosteroid monotherapy ... See more keywords
Short-term Outcomes of Corticosteroid Monotherapy in COVID-19-Associated Multisystem Inflammatory Syndrome in Children-Handle With Caution.
Sign Up to like & getrecommendations! Published in 2022 at "JAMA pediatrics"
DOI: 10.1001/jamapediatrics.2022.2325
Abstract: Short-term Outcomes of Corticosteroid Monotherapy in COVID-19–Associated Multisystem Inflammatory Syndrome in Children— Handle With Caution To the Editor I thank Villacis-Nunez and colleagues1 for their cohort study comparing short-term patient outcomes based on initial treatment… read more here.
Keywords: corticosteroid monotherapy; group; monotherapy; study ... See more keywords
Response to Topical Corticosteroid Monotherapy in Mycosis Fungoides.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of the American Academy of Dermatology"
DOI: 10.1016/j.jaad.2020.05.043
Abstract: BACKGROUND Topical corticosteroids alone or in combination with other therapies are widely used to treat Mycosis Fungoides (MF), but data on response rates to their use as monotherapy in MF are limited. OBJECTIVE Evaluate the… read more here.
Keywords: topical corticosteroid; response; mycosis fungoides; corticosteroid monotherapy ... See more keywords